Clinical Trial Detail

NCT ID NCT02227667
Title Evaluate the Efficacy of MEDI4736 in Immunological Subsets of Advanced Colorectal Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements no
Sponsors Memorial Sloan Kettering Cancer Center
Indications

colorectal cancer

Therapies

Durvalumab

Age Groups: adult

No variant requirements are available.